MIRAGEN THERAPEUTICS, INC. Human Resources Contracts & Agreements
60 Contracts & Agreements
- Bonus & Incentive Agreements (25 contracts)
- Compensation Agreements (1)
- Consulting Agreements (4)
- Employment Agreements (26)
- Separation Agreements (4)
- Viridian Therapeutics, Inc. Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on June 20, 2024)
- Form of Restricted Stock Award Agreement under the 2016 Equity Incentive Plan (Filed With SEC on February 27, 2024)
- Form of Stock Option Grant Notice and Stock Option Agreement under 2016 Equity Incentive Plan (Filed With SEC on February 27, 2024)
- Jennifer Tousignant Employment Agreement, dated January 10, 2024 (Filed With SEC on February 27, 2024)
- Amendment to Seth Harmon Employment Agreement, dated September 28, 2023 (Filed With SEC on February 27, 2024)
- Seth Harmon Employment Agreement, dated April 24, 2023 (Filed With SEC on February 27, 2024)
- Thomas Ciulla Employment Agreement, dated January 12, 2023 (Filed With SEC on February 27, 2024)
- Lara Meisner Employment Agreement, dated May 11, 2023 (Filed With SEC on February 27, 2024)
- Thomas Beetham Employment Agreement, dated October 27, 2023 (Filed With SEC on November 13, 2023)
- Stephen Mahoney Employment Agreement, dated October 27, 2023 (Filed With SEC on November 13, 2023)
- Viridian Therapeutics, Inc. Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on June 16, 2023)
- Jonathan Violin General Release and Separation and Consulting Agreement, dated February 6, 2023 (Filed With SEC on February 6, 2023)
- Scott Myers Employment Agreement, dated December 29, 2022 (Filed With SEC on February 6, 2023)
- Viridian Therapeutics, Inc. Amended & Restated 2016 Equity Incentive (Filed With SEC on August 15, 2022)
- Carrie Melvin Employment Agreement, dated May 25, 2022 (Filed With SEC on June 23, 2022)
- Kristian Humer Employment Agreement, dated June 9, 2021 (Filed With SEC on July 26, 2021)
- Consulting Agreement, dated as of February 1, 2021, by and between the Registrant and William S. Marshall, Ph.D (Filed With SEC on May 7, 2021)
- Form of 2020 Incentive Stock Option Grant Notice under Viridian Therapeutics, Inc. 2020 Stock Incentive Plan (Filed With SEC on March 26, 2021)
- Amended and Restated 2016 Equity Incentive Plan (Filed With SEC on March 26, 2021)
- Separation and Release Agreement, dated as of September 27, 2020 by and between the Registrant and Diana Escolar, M.D (Filed With SEC on March 26, 2021)
- Employment Agreement by and between the Registrant and Barrett Katz, M.D., dated as of January 18, 2021 (Filed With SEC on March 26, 2021)
- Separation and Release Agreement by and between the Company and Lee Rauch, dated as of January 15, 2020 (Filed With SEC on January 20, 2021)
- Employment Agreement by and between the Company and Jonathan Violin, dated as of January 15, 2021 (Filed With SEC on January 20, 2021)
- Bonus Agreement, dated as of September 14, 2020, by and between the Registrant and Jason Leverone (Filed With SEC on November 12, 2020)
- Consulting Agreement, dated as of October 16, 2020, by and between the Registrant and William S. Marshall, Ph.D (Filed With SEC on November 12, 2020)
- Separation Agreement, dated as of October 15, 2020, by and between the Registrant and William S. Marshall, Ph.D (Filed With SEC on November 12, 2020)
- Bonus Agreement, dated as of September 27, 2020, by and between the Company and Diana Escolar, M.D (Filed With SEC on October 1, 2020)
- Form of Bonus Agreement, dated as of September 14, 2020, by and between the Company and Diana Escolar, M.D (Filed With SEC on September 17, 2020)
- Form of Bonus Agreement, dated as of September 14, 2020, by and between the Company and Jason Leverone (Filed With SEC on September 17, 2020)
- Amended and Restated Employment Agreement, dated as of September 14, 2020, by and between the Company and Lee Rauch (Filed With SEC on September 17, 2020)
- Form of Consulting Agreement, dated as of September 14, 2020, by and between the Company and William S. Marshall, Ph.D (Filed With SEC on September 17, 2020)
- Form of Separation Agreement, dated as of September 14, 2020, by and between the Company and William S. Marshall, Ph.D (Filed With SEC on September 17, 2020)
- Employment Agreement by and between the Registrant and Lee Rauch, dated as of June 16, 2020 (Filed With SEC on June 19, 2020)
- Employment Agreement by and between the Registrant and Diana Escolar, M.D., dated as of February 20, 2020 (Filed With SEC on March 13, 2020)
- Miragen Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on May 11, 2017)
- MIRAGEN THERAPEUTICS, INC. RESTRICTED STOCK AWARD GRANT NOTICE (2016 EQUITY INCENTIVE PLAN) (Filed With SEC on May 11, 2017)
- MIRAGEN THERAPEUTICS, INC. STOCK OPTION GRANT NOTICE (2008 EQUITY INCENTIVE PLAN) (Filed With SEC on December 2, 2016)
- MIRAGEN THERAPEUTICS, INC. 2008 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MAY 16, 2008; AMENDED JUNE 18, 2009; APRIL 9, 2012 AND OCTOBER 28, 2015 APPROVED BY THE... (Filed With SEC on December 2, 2016)
- SIGNAL GENETICS, INC. 2016 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on December 2, 2016)
- MIRAGEN THERAPEUTICS, INC. EMPLOYMENT AGREEMENT (Filed With SEC on December 2, 2016)
